Welcome to our dedicated page for Borealis Foods SEC filings (Ticker: BRLSW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Want to know where Borealis Foods’ plant-protein revenue is headed or how supply-chain costs affect margins? Investors often dive into Borealis Foods insider trading Form 4 transactions or search for a Borealis Foods quarterly earnings report 10-Q filing just to answer these questions. Yet the disclosures span hundreds of pages and multiple forms.
Stock Titan shortens that journey. Our platform delivers Borealis Foods SEC filings explained simply with AI-powered summaries that spotlight sustainability commitments, ingredient sourcing risks, and segment sales growth. Need real-time alerts? Borealis Foods Form 4 insider transactions real-time appear on your dashboard seconds after EDGAR posts. Our coverage includes:
- Borealis Foods annual report 10-K simplified—understand long-term strategy, ESG metrics, and R&D spend on plant-based nutrition.
- Borealis Foods earnings report filing analysis—quarter-over-quarter revenue trends without wading through dense accounting notes.
- Borealis Foods proxy statement executive compensation—see how leadership incentives align with sustainability goals.
- Borealis Foods 8-K material events explained—track recalls, facility expansions, or new protein technologies as they happen.
- Borealis Foods executive stock transactions Form 4—monitor buying or selling before key announcements.
Understanding Borealis Foods SEC documents with AI means you can compare ingredient cost exposure, evaluate inventory levels, or flag patterns in insider sales—all in minutes. Whether you’re preparing a model, assessing ESG risk, or confirming market-moving events, the data arrives complete and clear, so you make informed decisions faster.
Borealis Foods Inc. reported interim results showing revenue growth alongside continued losses and significant liquidity pressure. Net revenue was $7,188,269 for the three months and $14,033,939 for the six months ended June 30, 2025, up from $5,325,280 and $13,220,713 in comparable 2024 periods. Gross profit for the three and six months was $514,885 and $1,414,687, respectively. The company recorded consolidated pre-tax losses of $4,586,139 for the quarter and $8,773,727 for the six months, producing basic and diluted loss per share of $(0.21) and $(0.41) for the three- and six-month periods. Total current liabilities were $39,423,539 and total liabilities $66,445,391 as of June 30, 2025, with material related-party notes of $18,854,580 outstanding. The independent auditor expressed substantial doubt about the company’s ability to continue as a going concern and the filing discloses material weaknesses in internal control. Cash equivalents were reported as none at June 30, 2025.